Skip to main content
. 2013 Jan 21;76(5):763–775. doi: 10.1111/bcp.12081

Figure 3.

Figure 3

S-COMT activity (% of baseline, pre-dose day 1) vs. time curve following the first (day 1) and last (day 8) doses of a 8 day once daily regimen with opicapone (n = 6 per dose group of opicapone; n = 7 for placebo). Inline graphic, placebo; Inline graphic, 5 mg; Inline graphic, 10 mg; Inline graphic, 20 mg; Inline graphic, 30 mg